Ferit Saraçoğlu

No ORCID on file · 1 paper in corpus · active 2003

Study types

  • article 1

Condition tags

  • dysmenorrhea 1
article 2003
·doi:10.1016/s0020-7292(03)00260-1

OBJECTIVES: To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea. METHODS: Fifty-five patients were included in this randomized, placebo-controlled, cross-over study. Pat…